Submission on Application to reassess
Quintozene (Application Code: ERMA200692)
To: Quintozene Submissions
ERMA New Zealand
PO Box 131
Wellington 6140
Email: submissions@ermanz.govt.nz
Fax:
(04) 914 0433
This submission relates to an application made by the Chief Executive of ERMA New
Zealand to reassess 'water dispersible granule or wettable powder containing 750g/kg
quintozene' to take into account that it contains dioxin as a contaminant.
ERMA New Zealand proposes the following preliminary recommendation:
that the approval for the quintozene-containing substance (HSR000742) shall be
revoked.
If you have any questions about making a submission please contact ERMA New Zealand on
0800 376 234 or visit www.ermanz.govt.nz for details.
Closing date for submissions: 16 March 2011
Your name:
Organisation name:
(if you are submitting
on its behalf)
Email:
Postal address:
Telephone number:
Privacy
Please keep my contact details confidential
ERMA New Zealand will deal with any personal information you supply in your submission in accordance
with the Privacy Act 1993. We will use your contact details for the purposes of processing the application
that it relates to (or in exceptional situations for other reasons permitted under the Privacy Act 1993).
Where your submission is made publicly available, your contact details will be removed only if you have
indicated this as your preference in the tick box above. We may also use your contact details for the
purpose of requesting your participation in customer surveys.
ERMA New Zealand is likely to post your submission on its website at www.ermanz.govt.nz. We also
may make your submission available in response to a request under the Official Information Act 1982.
Page 1
We recommend that you read the full application before completing
your submission. The application can be downloaded from:
www.ermanz.govt.nz/find/webResults.aspx?search=erma200692
Decision sought
Please select one option
I support the recommendation in this application and would like it approved (i.e. the
approval for quintozene would be revoked)
OR
I oppose the recommendation in this application and would like it declined (i.e. the
approval for quintozene would be retained)
OR
I neither support nor oppose the recommendation in this application
Hearing
Please select one option
I wish to speak at a hearing in support of my submission
OR
I do not wish to speak at a hearing in support of my submission
Revocation of the approval for the substance
containing quintozene with its associated dioxin
contaminant.
ERMA New Zealand is proposing that the approval for the substance containing quintozene
that is used to control fungal diseases in seeds, bulbs and recreational turf is revoked.
Non-negligible adverse effects on human health and the environment have been identified
from the use of quintozene with its dioxin contaminant and alternative fungicidal products
that can replace quintozene have been identified.
Time limit
The application proposes that the use of quintozene be discontinued and that any stocks must
be used up within 6 months.
Do you have any comments about this proposed duration of time allowed to use up stocks?
Do you have any comment about the proposal that no additional controls are applied during
that 6 month period?
Page 2
Information sought by the applicant (ERMA New
Zealand)
ERMA New Zealand is seeking further information in the following areas which may help us to
assess the risks, costs and benefits.
Are there any uses of quintozene not covered in the application?
Do you have any information on application rates or methods which differ from those used in
the assessment?
Effects on society and communities
What potential adverse effects might the continued used of quintozene wit its dioxin
contaminant have on society and communities?
What potential positive effects might the continued used of quintozene with its dioxin
contaminant have on society and communities?
Effects on the environment
What potential adverse effects might the continued used of quintozene with its dioxin
contaminant have on the environment?
Can you provide any ecotoxicological, persistence, or fate data that should be taken into
account in the assessment, particularly in relation the assessment of risks to:
- birds and bees;
- aquatic and terrestrial plants;
- soil organisms;
- terrestrial invertebrates (other than bees)?
Page 3
Are there other controls that can be applied to address risks to the environment?
Effects on human health and safety
What potential adverse effects might the continued used of quintozene with its dioxin
contaminant have on human health and safety?
Do you have any information which can refine the assessment of the risks to human health
from the quintozene or its dioxin contaminant? (Such as information on work practice, or use
of personal protective equipment which will adequately protect human health).
Do you have any comments on whether the assessment of the risks to human health from
the dioxin contaminant is appropriate?
What potential positive effects might the continued used of quintozene have on human
health and safety?
Page 4
Effects on the market economy
What potential adverse effects might the continued used of quintozene with its dioxin
contaminant have on the market economy?
What potential positive effects might the continued used of quintozene have on the market
economy? In particular, do you have any comments on whether the alternative fungicides
that are available can adequately replace all quintozene uses, including costs to growers?
Effects on Māori culture and values
What potential adverse effects might the continued used of quintozene with its dioxin
contaminant have on Māori culture and values?
What potential positive effects might the continued used of quintozene have on Māori
culture and values?
Additional Information
Is there any additional information you would like to provide to help us assess the risks, costs and
benefits?
Page 5